Navigation Links
Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709

High Concentrations Reached in Key Lung Compartments

REINACH and BASEL, Switzerland, March 29, 2007 /PRNewswire-FirstCall/ -- Arpida Ltd. today announced promising results of "first-in-man" studies with AR-709. These radiolabelled Human Microdose studies included a total of 19 healthy male volunteers.

This groundbreaking study is the first ever using Microdosing for the determination of drug concentrations in lung compartments. The results showed that AR-709 achieves high concentrations in bronchial mucosa (BM), epithelial lining fluid (ELF) and alveolar macrophages (AM), the three key compartments of the lungs where pathogens can reside and replicate. Moreover, the results of the studies show that AR-709 exhibited a large volume of distribution and a long half life in man. Oral bioavailability was potentially low but this could be due to the low dose, poor absorption or extensive metabolism.

The studies were conducted at Hammersmith Medicines Research Ltd (London, UK) under MHRA regulatory authorisation and were coordinated by Xceleron Ltd (York, UK), the exploratory clinical development specialist and world leader in the field of Human Microdosing.

Dr Sergio Lociuro, Head of Research of Arpida Ltd. commented "I am very pleased with the results of this first human trial with AR-709. They clearly show that the compound distributes well throughout the body and more importantly in the lungs. In a substantial number of cases, community-acquired respiratory tract infections, caused by S. pneumoniae, require hospitalisation and intravenous therapy. AR-709 appears to have the necessary characteristics to eradicate the microorganisms that can result in serious infections. For cases not requiring hospitalisation and/or to accelerate patient discharge from the hospital, targeted delivery, e.g. via inhalation, could provide a valid and promising alternative to administration via the oral route. Altho
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Arpida adds novel antibiotic AR-2474 to its preclinical pipeline
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Arpida Announces Promising Results First Man Studies With
(Date:12/19/2014)... , Dec. 18, 2014   Aratana Therapeutics, ... biopharmaceutical company focused on the licensing, development and ... announced positive results from its pivotal field study ... treating pain in dogs with osteoarthritis.  In the ... assessment scores that were statistically significant compared to ...
(Date:12/17/2014)... and SAN DIEGO , Dec. 17, 2014 ... ; AEX: PHIA) and Volcano Corporation (NASDAQ: VOLC ... for cardiovascular applications, today announced that they have entered into ... commence a tender offer to acquire all of the issued ... or a total equity purchase price of USD 1 billion ...
(Date:12/17/2014)... 17, 2014  Strategic Health Services, Inc. (SHS), a ... announced a strategic agreement with QualCare, Inc., a leading provider ... regional marketplace.  This agreement will further QualCare,s ... wellness solutions QualCare brings to its clients in ... QualCare plans cover more than 800,000 ...
Breaking Medicine Technology:Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3
... Reportlinker.com announces that a new market research ... Pharmaceutical Packaging Industry - 2011 ... Pharmaceutical Packaging Industry - 2011 ... GBI Research, the leading business intelligence ...
... China, Nov. 28, 2011 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain ... the "Company"), the largest retail drugstore chain in China ... announced its unaudited financial results for the third quarter ... HighlightsFor the quarter ended September 30, 2011: ...
Cached Medicine Technology:Pharmaceutical Packaging Industry - 2011 Yearbook 2Pharmaceutical Packaging Industry - 2011 Yearbook 3Pharmaceutical Packaging Industry - 2011 Yearbook 4Pharmaceutical Packaging Industry - 2011 Yearbook 5Pharmaceutical Packaging Industry - 2011 Yearbook 6Pharmaceutical Packaging Industry - 2011 Yearbook 7Pharmaceutical Packaging Industry - 2011 Yearbook 8Pharmaceutical Packaging Industry - 2011 Yearbook 9China Nepstar Chain Drugstore Reports Third Quarter 2011 Financial Results 2China Nepstar Chain Drugstore Reports Third Quarter 2011 Financial Results 3China Nepstar Chain Drugstore Reports Third Quarter 2011 Financial Results 4China Nepstar Chain Drugstore Reports Third Quarter 2011 Financial Results 5China Nepstar Chain Drugstore Reports Third Quarter 2011 Financial Results 6China Nepstar Chain Drugstore Reports Third Quarter 2011 Financial Results 7China Nepstar Chain Drugstore Reports Third Quarter 2011 Financial Results 8China Nepstar Chain Drugstore Reports Third Quarter 2011 Financial Results 9
(Date:12/20/2014)... BambooIndustry.com is a professional company offering many kinds ... shown its new engineered bamboo flooring collection, and announced ... , BambooIndustry.com’s customers come from many countries in the ... the CEO of the company, the global bamboo flooring ... few years, and the demand for eco-friendly bamboo flooring ...
(Date:12/20/2014)... New York, NY (PRWEB) December 20, 2014 ... with the healthcare sector have benefited the Massage ... Given the discretionary characteristics of industry products, the anticipated ... the five-year period has provided consumers with the means ... adults that have received a massage in a given ...
(Date:12/20/2014)... News) -- The holidays can be anything but joyous ... trees, scented candles and other allergy triggers. "The ... have been packed away in dank basements or dusty ... patients," Dr. Rachna Shah, an affiliate faculty member at ... Loyola news release. Shah, who is also an ...
(Date:12/20/2014)... York, New York (PRWEB) December 20, 2014 ... continue to move forward in U.S. courts, ... new study which suggests that children treated with ... a hormone linked to breast development and lactation. ... looked at 34 children and adolescents who began ...
(Date:12/20/2014)... December 20, 2014 Developers of ... of a new plugin for Final Cut Pro X ... “TranSlice Volume 5 allows users to create hand drawn ... Said Christina Austin, CEO of Pixel Film Studios. “TranSlice ... professionalism while maintaining an easy to use interface.” , ...
Breaking Medicine News(10 mins):Health News:BammbooIndustry.com: Big Discounts On All Kinds Of Bamboo Flooring Collections 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Holiday Trimmings Can Trigger Allergies 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 4Health News:Pixel Film Studios released a new transition entitled TranSlice Volume 5 exclusively for Final Cut Pro X 2
... doctor was acquitted on Wednesday of murdering three of his ... Martin, 71, a retired army officer from North Wales, was ... the lives of three seriously ill men, after a six-week ... look into the deaths of other patients under the care ...
... the first to visualize a need for laboratories in the Mexican ... Sustainability Laboratory (BNSL), which extends over an area of 4000 square ... security force and deal with terrorism // with the help ... for the lab come from USA, State of New Mexico and ...
... Barry D. Weiss, professor of family and community medicine and ... among patients. // ,They developed a tool which is ... minute questionnaire with six questions based on an ice cream ... by the patient their health literacy can be calculated. ...
... Gabriella gobbi and his team from Universite de ... increases the level of endocannabinoids by blocking the ... are chemicals present in brain which is responsible ... brain receptors are triggered during exercises and other ...
... Internal Medicine this week have found that the standard ... kidney failure is useless. //The study conducted by researchers ... found that a treatment called "plasma exchange" in patients ... means that the money which is currently spent in ...
... study conducted by the University of Alberta has revealed that ... mental health before its parents divorce. //The study does not ... More attention should be paid to the child while the ... the event has already occurred, according to Dr. Lisa Strohschein. ...
Cached Medicine News:Health News:British Doctor cleared of murder 2
Slightly curved blunt dissector, double-ended. Length 11 1/2" (272 mm)...
Leroy-Raney scalp clips, sterile, disposable, plastic, ten clips/package....
Disposable scalp clip applier, comes loaded with 12 Leroy-Raney clips, ergonomic, easy to handle and position the clip....
... of comminution, aspiration and irrigation ... ultra-sonic energy. Allows for preservative ... particular, parenchymatous organs, offering the ... non-traumatic preparation with a low ...
Medicine Products: